MedTrace Logo

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

NCT01115595 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2019-03-18

No results posted yet for this study

Summary

The purpose of this study is to study the efficacy of allergen injection immunotherapy for allergic rhinitis by

* symptoms score
* medication score
* quality of life
* immunologic test from blood

Conditions

  • Rhinitis, Allergic, Perennial

Interventions

BIOLOGICAL

Intervention

Dermatophagoides pteronyssinus from ALK company

OTHER

Control

Injection by buffer solution WITH standard allergic medication (oral antihistamine and/or topical nasal steroid)

Sponsors & Collaborators

  • National Research Council of Thailand

    collaborator OTHER_GOV

  • Pongsakorn Tantilipikorn

    lead OTHER

Principal Investigators

  • Pongsakorn Tantilipikorn, M.D. · Division of allergy and rhinology, Faculty of Medicine Siriraj, Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-10-31
Completion
2014-10-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01115595 on ClinicalTrials.gov